Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bone Biologics Corporation (BBLG)
USD1.30
+0.04 (+3.17%)
US NASDAQ Healthcare Medical - Devices
Address
2 Burlington Woods Drive 1803
Burlington, MA, US
Burlington, MA, US
CEO
Jeffrey Frelick
Website
bonebiologics.com
IPO
2021-10-13
CIK 1419554 ISIN US0980706008
Also trades on
NASDAQ Capital Market · BBLG (USD)
NASDAQ Capital Market · BBLGW (USD)
Description
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.30
+0.04 (+3.17%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
48.0K
Beta
0.56
Float Shares
1.79M
Free Float %
100.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.27% | -1.55% | +0.79% | +6.72% | -20.63% | -12.41% | -71.40% | -99.05% | -99.96% | -99.96% | -99.96% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.30
DCF (Unlevered)
4.21
+224.2%
DCF (Levered)
4.54
+249.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-21.37
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%+45.1% ★ Q1'26: -34.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%—
-
EBIT margin Medical - Devices: +6.2%—
-
ROIC Medical - Devices: +3.3%-7,192.4% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-22.6% ★ Q1'26: -43.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 EPS Ana. |
Dec 2027 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
—
|
—
|
—
— – —
|
—
— – —
|
| EBITDA |
107.2K
|
-3.11M
|
—
— – —
|
—
— – —
|
| EBIT |
-4.11M
|
-3.11M
|
—
— – —
|
—
— – —
|
| Net Income |
-4.11M
est: -28.85M (+85.7%)
|
-3.11M
est: -2.77M (-12.1%)
|
-2.27M
-2.27M – -2.27M
+18.2% YoY
|
-1.90M
-1.90M – -1.90M
+16.1% YoY
|
| SGA |
2.09M
|
2.17M
|
—
— – —
|
—
— – —
|
| EPS |
-4.83
est: -19.02 (+74.6%)
|
-2.65
est: -2.36 (-12.3%)
|
-1.93
-1.93 – -1.93
+18.2% YoY
|
-1.62
-1.62 – -1.62
+16.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
14
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Orthofix Holdings, Inc. | 2.65M | 6.00% | — | 2.65M | — | — | CO | Curacao | 2018-04-03 | ↗ |
| 2 | Orthofix International N.V. | 2.65M | 6.00% | — | 2.65M | — | — | CO | Curacao | 2018-04-03 | ↗ |
| 3 | NAME OF REPORTING PERSONS | 1.24M | 9.00% | — | 1.24M | — | 1.24M | — | USA | 2023-01-04 | ↗ |
| 4 | Walleye Capital LLC | 830.2K | 5.43% | 830.2K | — | 830.2K | — | IA | Minnesota | 2023-02-14 | ↗ |
| 5 | S | 740.7K | 5.24% | — | 740.7K | — | 740.7K | OO | California, United States | 2022-10-12 | ↗ |
| 6 | Jeff Easton | 203.0K | 6.50% | 203.0K | — | 203.0K | — | IN | Delaware | 2023-06-26 | ↗ |
| 7 | Lind Global Fund II LP | 203.0K | 6.50% | 203.0K | — | 203.0K | — | PN | Delaware | 2023-06-26 | ↗ |
| 8 | Lind Global Partners II LLC | 203.0K | 6.50% | 203.0K | — | 203.0K | — | OO | Delaware | 2023-06-26 | ↗ |
| 9 | Daniel B. Asher | 99.6K | 9.99% | — | 99.6K | — | 84.8K | HC, IN | Citizenship or Place of Organization United States of America | 2024-03-14 | ↗ |
| 10 | Intracoastal Capital LLC | 99.6K | 9.99% | — | 99.6K | — | 84.8K | OO | Citizenship or Place of Organization Delaware | 2024-03-14 | ↗ |
| 11 | Mitchell P. Kopin | 99.6K | 9.99% | — | 99.6K | — | 84.8K | HC, IN | Citizenship or Place of Organization United States of America | 2024-03-14 | ↗ |
| 12 | Brendan O’Neil | 55.2K | 9.99% | — | 55.2K | — | 55.2K | IN | United States | 2023-12-20 | ↗ |
| 13 | Ionic Ventures, LLC | 55.2K | 9.99% | — | 55.2K | — | 55.2K | OO | California, United States | 2023-12-20 | ↗ |
| 14 | Keith Coulston | 55.2K | 9.99% | — | 55.2K | — | 55.2K | IN | United States | 2023-12-20 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
251.6K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+251,576
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | Walsh Deina H | Officer | A-Award | A | Employee Stock Option | 8,335 | 1.55 | 12.9K | 8,335 | D | ↗ |
| 2026-01-08 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option | 16,668 | 1.55 | 25.8K | 16,668 | D | ↗ |
| 2025-06-04 | Stroever Bruce | Director | A-Award | A | Non-Employee Stock Option | 62,894 | 0.88 | 55.3K | 62,894 | D | ↗ |
| 2025-06-04 | Meikle Phillip Terry II | Director | A-Award | A | Non-Employee Stock Option | 62,894 | 0.88 | 55.3K | 62,894 | D | ↗ |
| 2025-06-04 | Gagnon Robert E. | Director | A-Award | A | Non-Employee Stock Option | 62,894 | 0.88 | 55.3K | 62,894 | D | ↗ |
| 2025-06-04 | Angle Siddhesh Rajendra | Director | A-Award | A | Non-Employee Stock Option | 62,894 | 0.88 | 55.3K | 62,894 | D | ↗ |
| 2025-01-15 | Walsh Deina H | Officer | A-Award | A | Employee Stock Option | 27,055 | 0.97 | 26.2K | 27,055 | D | ↗ |
| 2025-01-15 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option | 54,110 | 0.97 | 52.4K | 54,110 | D | ↗ |
| 2024-10-16 | Meikle Phillip Terry II | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-17 | Stroever Bruce | Director | A-Award | A | Non-Employee Stock Option | 30,713 | 1.73 | 53.1K | 30,713 | — | ↗ |
| 2024-09-17 | Gagnon Robert E. | Director | A-Award | A | Non- Employee Stock Option | 30,713 | 1.73 | 53.1K | 30,713 | — | ↗ |
| 2024-09-17 | Angle Siddhesh Rajendra | Director | A-Award | A | Non-Employee Stock Option | 30,713 | 1.73 | 53.1K | 30,713 | — | ↗ |
| 2024-01-17 | Walsh Deina H | Officer | A-Award | A | Employee Stock Option | 12,500 | 3.61 | 45.1K | 12,500 | — | ↗ |
| 2024-01-17 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option | 25,000 | 3.61 | 90.3K | 25,000 | — | ↗ |
| 2024-01-08 | Gagnon Robert E. | Director | A-Award | A | Non-Employee Stock Option | 8 | 4.68 | 37.47 | 8,015 | — | ↗ |
| 2023-09-18 | Stroever Bruce | Director | A-Award | A | Non-Employee Stock Option | 85,763 | 0.64 | 54.9K | 85,763 | — | ↗ |
| 2023-09-18 | Lucera Erick | Director | A-Award | A | Non-Employee Stock Option | 85,763 | 0.64 | 54.9K | 85,763 | — | ↗ |
| 2023-09-18 | Angle Siddhesh Rajendra | Director | A-Award | A | Non-Employee Stock Option | 85,763 | 0.64 | 54.9K | 85,763 | — | ↗ |
| 2023-09-13 | Walsh Deina H | Officer | P-Purchase | A | Common Stock | 8,000 | 0.64 | 5.1K | 15,000 | — | ↗ |
| 2023-09-11 | Frelick Jeff | Officer | P-Purchase | A | Common Stock | 9,500 | 0.69 | 6.5K | 17,204 | — | ↗ |
| 2023-09-06 | Walsh Deina H | Officer | P-Purchase | A | Common Stock | 6,700 | 0.71 | 4.8K | 7,000 | — | ↗ |
| 2023-08-31 | Frelick Jeff | Officer | P-Purchase | A | Common Stock | 7,600 | 0.66 | 5.0K | 7,704 | — | ↗ |
| 2023-03-13 | Hankey Don | Director / Officer / 10% Owner | J-Other | A | Warrants to Purchase Common Stock | 19,297 | 6.30 | 121.6K | 19,297 | — | ↗ |
| 2023-01-25 | Walsh Deina H | Officer | A-Award | A | Employee Stock Option | 18,875 | 0.24 | 4.5K | 43,875 | — | ↗ |
| 2023-01-25 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option | 37,750 | 0.24 | 9.1K | 140,140 | — | ↗ |
| 2022-08-23 | Stroever Bruce | Director | A-Award | A | Non-Employee Stock Option | 36,845 | 1.61 | 59.3K | 48,516 | — | ↗ |
| 2022-08-23 | Lucera Erick | Director | A-Award | A | Non-Employee Stock Option | 36,845 | 1.61 | 59.3K | 68,516 | — | ↗ |
| 2022-08-23 | Angle Siddhesh Rajendra | Director | A-Award | A | Non-Employee Stock Option | 36,845 | 1.61 | 59.3K | 68,516 | — | ↗ |
| 2022-01-03 | Walsh Deina H | Officer | A-Award | A | Employee Stock Option | 25,000 | 3.72 | 93.0K | 25,000 | — | ↗ |
| 2022-01-01 | Stroever Bruce | Director | A-Award | A | Non-Employee Stock Option | 8,722 | 3.52 | 30.7K | 11,671 | — | ↗ |
| 2022-01-01 | Lucera Erick | Director | A-Award | A | Non-Employee Stock Option | 8,722 | 3.52 | 30.7K | 31,671 | — | ↗ |
| 2022-01-01 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option | 50,000 | 3.72 | 186.0K | 102,389 | — | ↗ |
| 2022-01-01 | Angle Siddhesh Rajendra | Director | A-Award | A | Non-Employee Stock Option | 8,722 | 3.52 | 30.7K | 31,671 | — | ↗ |
| 2021-10-26 | Stroever Bruce | Director | A-Award | A | Non-Employee Stock Option | 2,949 | 5.25 | 15.5K | 2,949 | — | ↗ |
| 2021-10-26 | Lucera Erick | Director | A-Award | A | Non-Employee Stock Option | 2,949 | 5.25 | 15.5K | 22,949 | — | ↗ |
| 2021-10-26 | Angle Siddhesh Rajendra | Director | A-Award | A | Non-Employee Stock Option | 2,949 | 5.25 | 15.5K | 22,949 | — | ↗ |
| 2021-10-15 | Lucera Erick | Director | — | D | Options to Purchase Common Stock | 50,000 | 5.25 | 262.5K | 0 | — | ↗ |
| 2021-10-15 | Hankey Don | Director / Officer / 10% Owner | C-Conversion | A | Common Stock | 5,928,774 | 2.50 | 14.82M | 16,915,624 | — | ↗ |
| 2021-10-15 | Angle Siddhesh Rajendra | Director | — | D | Options to Purchase Common Stock | 50,000 | 5.25 | 262.5K | 0 | — | ↗ |
| 2020-01-02 | Hankey Don | Officer | P-Purchase | A | Common Stock | 195,000 | 1.00 | 195.0K | 28,563,398 | — | ↗ |
| 2020-01-02 | Hankey Bret | Director | P-Purchase | A | Common Stock | 195,000 | 1.00 | 195.0K | 28,122,518 | — | ↗ |
| 2019-08-06 | Hankey Don | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 553,191 | 0.00 | — | 28,465,740 | — | ↗ |
| 2019-08-06 | Hankey Bret | Director | P-Purchase | A | Common Stock | 553,191 | 0.00 | — | 27,829,860 | — | ↗ |
| 2019-07-15 | Hankey Don | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 85,106 | 0.00 | — | 27,912,549 | — | ↗ |
| 2019-07-15 | Hankey Bret | Director | P-Purchase | A | Common Stock | 85,106 | 0.00 | — | 0 | — | ↗ |
| 2019-06-20 | Hankey Don | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,063,830 | 0.00 | — | 0 | — | ↗ |
| 2019-06-20 | Hankey Bret | Director | P-Purchase | A | Common Stock | 1,063,830 | 0.00 | — | 27,191,563 | — | ↗ |
| 2019-05-07 | Hankey Don | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,063,830 | 0.00 | — | 26,763,613 | — | ↗ |
| 2019-05-07 | Hankey Bret | Director | P-Purchase | A | Common Stock | 1,063,830 | 0.00 | — | 26,127,733 | — | ↗ |
| 2019-03-25 | Hankey Don | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,489,362 | 0.00 | — | 25,699,783 | — | ↗ |
| 2019-03-25 | Hankey Bret | Director | P-Purchase | A | Common Stock | 1,489,362 | 0.00 | — | 25,063,903 | — | ↗ |
| 2019-01-01 | Booth John J | Director | A-Award | A | Non-Employee Stock Option | 54,909 | 0.94 | 51.6K | 67,054 | — | ↗ |
| 2018-12-17 | Hankey Don | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 18,009,696 | 0.00 | — | 24,210,421 | — | ↗ |
| 2018-12-17 | Hankey Bret | Director | P-Purchase | A | Common Stock | 18,009,696 | 0.00 | — | 23,013,754 | — | ↗ |
| 2018-07-16 | Hankey Don | Director / Officer / 10% Owner | — | I | Warrants | 146,342 | 20.50 | 3.00M | 0 | — | ↗ |
| 2018-02-16 | Walsh Deina H | Officer | A-Award | A | Restricted Stock Unit | 28,426 | 0.00 | — | 39,530 | — | ↗ |
| 2018-02-16 | La Neve Stephen R. | Officer | A-Award | A | Restricted Stock Unit | 142,132 | 0.00 | — | 176,546 | — | ↗ |
| 2018-02-16 | Frelick Jeff | Officer | A-Award | A | Restricted Stock Unit | 60,914 | 0.00 | — | 77,377 | — | ↗ |
| 2018-01-01 | Delshad Jim | Director | A-Award | A | Non-Employee Stock Option | 26,109 | 1.97 | 51.4K | 121,442 | — | ↗ |
| 2018-01-01 | Booth John J | Director | A-Award | A | Non-Employee Stock Option | 26,109 | 1.97 | 51.4K | 121,442 | — | ↗ |
| 2017-11-29 | Heshmatpour Amir F | 10% Owner | J-Other | A | Common Stock | 915,614 | 0.00 | — | 2,942,393 | — | ↗ |
| 2017-09-07 | Heshmatpour Amir F | 10% Owner | J-Other | A | Common Stock | 200,000 | 0.00 | — | 2,026,779 | — | ↗ |
| 2017-07-31 | Hankey Bret | Director | — | D | Common Stock | 0 | 0.00 | — | 28,034 | — | ↗ |
| 2017-01-01 | Delshad Jim | Director | A-Award | A | Non-Employee Stock Option | 26,780 | 2.05 | 54.9K | 95,333 | — | ↗ |
| 2017-01-01 | Booth John J | Director | A-Award | A | Non-Employee Stock Option | 26,780 | 2.05 | 54.9K | 95,333 | — | ↗ |
| 2016-07-14 | AFH Holding & Advisory, LLC | 10% Owner | D-Return | D | Common Stock | 5,000 | 5.00 | 25.0K | 3,768,358 | — | ↗ |
| 2016-07-06 | AFH Holding & Advisory, LLC | 10% Owner | A-Award | A | Common Stock | 23,173 | 5.00 | 115.9K | 3,773,358 | — | ↗ |
| 2016-05-27 | La Neve Stephen R. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 538,290 | 2.05 | 1.10M | 2,653,895 | — | ↗ |
| 2016-05-27 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 269,145 | 2.05 | 551.7K | 1,326,204 | — | ↗ |
| 2016-05-20 | AFH Holding & Advisory, LLC | 10% Owner | J-Other | D | Common Stock | 915,614 | 4.95 | 4.53M | 3,729,999 | — | ↗ |
| 2016-03-25 | Walsh Deina H | Officer | A-Award | A | Restricted Stock | 11,104 | 0.00 | — | 11,104 | — | ↗ |
| 2016-03-25 | La Neve Stephen R. | Officer | A-Award | A | Restricted Stock | 34,414 | 0.00 | — | 34,414 | — | ↗ |
| 2016-03-25 | Frelick Jeff | Officer | A-Award | A | Restricted Stock | 16,463 | 0.00 | — | 16,463 | — | ↗ |
| 2016-03-14 | Treat William Jay | Officer | A-Award | A | Stock Option (right to buy) | 54,000 | 2.05 | 110.7K | 54,000 | — | ↗ |
| 2016-02-29 | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | 10% Owner | P-Purchase | A | Common Stock | 731,707 | 2.05 | 1.50M | 11,640,096 | — | ↗ |
| 2015-12-31 | Booth John J | Director | G-Gift | D | Common Stock | 20,000 | 0.00 | — | 20,822 | — | ↗ |
| 2015-12-28 | Walsh Deina H | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 465,795 | 1.59 | 740.6K | 465,795 | — | ↗ |
| 2015-12-28 | WU BENJAMIN | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.59 | 79.5K | 50,000 | — | ↗ |
| 2015-12-28 | WARNECKE STEVE B | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.59 | 79.5K | 50,000 | — | ↗ |
| 2015-12-28 | Treat William Jay | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 799,414 | 1.59 | 1.27M | 799,414 | — | ↗ |
| 2015-12-28 | SOO B CHIA | Director | A-Award | A | Stock Option (Right to Buy) | 68,553 | 1.59 | 109.0K | 68,553 | — | ↗ |
| 2015-12-28 | La Neve Stephen R. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 2,081,191 | 1.59 | 3.31M | 2,081,191 | — | ↗ |
| 2015-12-28 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,040,596 | 1.59 | 1.65M | 1,040,596 | — | ↗ |
| 2015-12-28 | Delshad Jim | Director | A-Award | A | Common Stock | 9,176 | 0.00 | — | 40,822 | — | ↗ |
| 2015-12-28 | COFFIN WILLIAM F | Director | A-Award | A | Stock Option (Right to Buy) | 68,553 | 1.59 | 109.0K | 68,553 | — | ↗ |
| 2015-12-28 | Booth John J | Director | A-Award | A | Common Stock | 9,176 | 0.00 | — | 40,822 | — | ↗ |
| 2015-12-22 | WU BENJAMIN | Director | S-Sale | D | Common Stock | 2,637 | 1.58 | 4.2K | 970,991 | — | ↗ |
| 2015-12-22 | SOO B CHIA | Director | S-Sale | D | Common Stock | 5,274 | 1.58 | 8.3K | 2,982,804 | — | ↗ |
| 2015-11-20 | AFH Holding & Advisory, LLC | 10% Owner | S-Sale | D | Common Stock | 7,911 | 1.58 | 12.5K | 3,385,358 | — | ↗ |
| 2015-10-27 | AFH Holding & Advisory, LLC | 10% Owner | A-Award | A | Common Stock | 915,614 | 0.00 | — | 3,393,269 | — | ↗ |
| 2015-10-22 | SOO B CHIA | Director | G-Gift | A | Common Stock | 2,000,000 | 0.00 | — | 2,978,902 | — | ↗ |
| 2015-10-19 | AFH Holding & Advisory, LLC | 10% Owner | A-Award | A | Common Stock | 5,000 | 1.58 | 7.9K | 2,477,655 | — | ↗ |
| 2015-10-09 | WU BENJAMIN | Director | S-Sale | D | Common Stock | 26,372 | 1.58 | 41.7K | 973,628 | — | ↗ |
| 2015-10-09 | SOO B CHIA | Director | S-Sale | D | Common Stock | 52,744 | 1.58 | 83.3K | 978,902 | — | ↗ |
| 2015-10-09 | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | Director | S-Sale | D | Common Stock | 26,372 | 1.58 | 41.7K | 973,628 | — | ↗ |
| 2015-10-09 | AFH Holding & Advisory, LLC | 10% Owner | S-Sale | D | Common Stock | 79,110 | 1.58 | 125.0K | 2,472,655 | — | ↗ |
| 2015-10-08 | WU BENJAMIN | Director | A-Award | A | Common Stock (Right to Acquire) | 384,615 | 0.00 | — | 384,615 | — | ↗ |
| 2015-10-08 | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | Director | A-Award | A | Common Stock (Right to Acquire) | 384,615 | 0.00 | — | 384,615 | — | ↗ |
| 2015-10-02 | SOO B CHIA | Director | A-Award | A | Common Stock (Right to Acquire) | 384,615 | 0.00 | — | 384,615 | — | ↗ |
| 2015-09-25 | WU BENJAMIN | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2015-09-25 | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2015-09-19 | WARNECKE STEVE B | Director | A-Award | A | Common Stock | 31,646 | 0.00 | — | 31,646 | — | ↗ |
| 2015-09-19 | SOO B CHIA | Director | A-Award | A | Common Stock | 31,646 | 0.00 | — | 1,031,646 | — | ↗ |
| 2015-09-19 | Delshad Jim | Director | A-Award | A | Common Stock | 31,646 | 0.00 | — | 31,646 | — | ↗ |
| 2015-09-19 | COFFIN WILLIAM F | Director | A-Award | A | Common Stock | 31,646 | 0.00 | — | 31,646 | — | ↗ |
| 2015-09-19 | Booth John J | Director | A-Award | A | Common Stock | 31,646 | 0.00 | — | 31,646 | — | ↗ |
| 2015-09-09 | AFH Holding & Advisory, LLC | 10% Owner | G-Gift | D | Common Stock | 100,000 | 0.00 | — | 2,851,765 | — | ↗ |
| 2015-08-17 | La Neve Stephen R. | Director / Officer | J-Other | D | Employee Stock Option (Right to Buy) | 2,081,191 | 1.58 | 3.29M | 0 | — | ↗ |
| 2015-08-17 | Frelick Jeff | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,040,596 | 1.58 | 1.64M | 1,040,596 | — | ↗ |
| 2015-08-12 | AFH Holding & Advisory, LLC | 10% Owner | A-Award | A | Common Stock | 867,163 | 0.00 | — | 2,951,765 | — | ↗ |
| 2014-11-24 | ORAM GEORGE A | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-11-04 | Walsh Deina H | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-19 | WARNECKE STEVE B | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-19 | Treat William Jay | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-19 | Stroever Bruce | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-19 | SOO B CHIA | Director | J-Other | A | Warrant (Right to Buy) | 119,318 | 0.44 | 52.5K | 119,318 | — | ↗ |
| 2014-09-19 | Delshad Jim | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-19 | COFFIN WILLIAM F | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-19 | Booth John J | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-09-18 | AFH Holding & Advisory, LLC | 10% Owner | G-Gift | D | Common Stock | 200,000 | 0.00 | — | 3,600,000 | — | ↗ |
| 2014-08-06 | AFH Holding & Advisory, LLC | 10% Owner | J-Other | D | Common Stock | 600,000 | 0.01 | 5.4K | 4,400,000 | — | ↗ |
| 2008-08-07 | Heshmatpour Amir F | Director / Officer / 10% Owner | J-Other | A | Common Stock | 5,000,000 | 0.00 | — | 5,000,000 | — | ↗ |
| 2008-08-07 | AFH Holding & Advisory, LLC | 10% Owner | — | D | Common Stock, par value $.001 per share | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2008-04-01 | Heshmatpour Amir F | Director / Officer | — | D | Common Stock, par value $.001 per share | 0 | 0.00 | — | 5,000,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
1.80M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jeffrey Frelick | Chief Executive Officer & President | 400.0K | male |
| Deina H. Walsh | Chief Financial Officer | 250.0K | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BBLG
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
